Artery-to-vein differences in nitric oxide metabolites are diminished in sepsis

Critical Care Medicine

Volumn 38, Issue 4, 2010, Pages 1069-1077

  Morgan, Mary Anne M ^a   Frasier, Lauren M ^a   Stewart, Judith C ^a   MacK, Cynthia M ^a   Gough, Michael S ^a   Graves, Brian T ^a   Apostolakos, Michael J ^a   Doolin, Kathleen P ^a   Darling, Denise C ^a   Frampton, Mark W ^a   Pietropaoli, Anthony P ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Critical care; Erythrocytes; Intensive care; Nitric oxide; Nitrites; Septic shock

Indexed keywords

HEMOGLOBIN DERIVATIVE; IRON NITROSYLHEMOGLOBIN; NITRIC OXIDE; NITRITE; NITROSAMINE; S NITROSOHEMOGLOBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; CASE CONTROL STUDY; CELL LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ERYTHROCYTE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METABOLITE; MORTALITY; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPTIC SHOCK; SURVIVOR; VENOUS BLOOD;

EID: 77950221960     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181d16a3e     Document Type: Article

References (44)

1. Landry D, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588-595
2. Trzeciak S, Cinel I, Dellinger P, et al: Resuscitating the microcirculation in sepsis: The central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008; 15: 399-413
3. MacKanzie I, Garrard CS, Young JD: Indices of nitric oxide synthesis and outcome in critically ill patients. Anaesthesia 2001; 56: 326-330
4. Gomez-Jimenez J, Salgado A, Mourelle M, et al: L-arginine: Nitric oxide pathway in endo-toxemia and human septic shock. Crit Care Med 1995; 23:253-258
5. Evans T, Carpenter A, Kinderman H, et al: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41:77-81
6. Groeneveld J, Hartemink KJ, deGroot MCM, et al: Circulating endothelin and nitrate-nitrite relate to hemodynamic and metabolic variables in human septic shock. Shock 1999; 11:160-166
7. Villalpando S, Gopal J, Balasubramanyam A, et al: In vivo arginine production and intra-vascular nitric oxide synthesis in hypotensive sepsis. Am J Clin Nutr 2006; 84:197-203
8. Luiking Y, Poeze M, Ramsay G, et al: Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production. Am J Clin Nutr 2009; 89:142-152
9. Lopez A, Lorente JA, Steingrub J, et al: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546c88: Effect on survival in patients with septic shock. Crit Care Med 2004; 32:21-30
10. Cannon R, Schechter AN, Panza JA, et al: Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest 2001; 108: 279-287
11. Jia L, Bonaventura C, Bonaventura J, et al: S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control. Nature 1996; 380:221-226
12. Gladwin M, Shelhamer JH, Schechter AN, et al: Role of circulating nitrite and s-nitroso-hemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci USA 2000; 97:11482-11487
13. Dejam A, Hunter CJ, Pelletier MM, et al: Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood 2005; 106:734-739
14. McMahon T, Moon RE, Luschinger BP, et al: Nitric oxide in the human respiratory cycle. Nat Med 2002; 8:711-717
15. Stamler J: Hemoglobin and nitric oxide (letter). N Engl J Med 2003; 349:402
16. Doctor A, Platt R, Sheram ML, et al: Hemoglobin conformation couples erythrocyte s-nitrosothiol content to O2 gradients. Proc Natl Acad Sci USA 2005; 102:5709-5714
17. Kehmeier E, Kropp M, Kleinbongard P, et al: Serial measurements of whole blood nitrite in an intensive care setting. Free Radic Biol Med 2008; 44:1945-1950
18. Liu L, Yan Y, Zeng M, et al: Essential role of s-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 2004; 116:617-628
19. Bone R, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644-1655
20. Yang B, Vivas EX, Reiter CD, et al: Methodologies for the sensitive and specific measurement of s-nitrosothils, iron-nitrosyls, and nitrite in biological samples. Free Radical Research 2003; 37:1-10
21. MacArthur P, Shiva S, Gladwin MT: Measurement of nitrite and s-nitrosothiols by reductive chemiluminescence. J Chromatography B 2007; 851:93-105
22. Cosby K, Partovi KS, Crawford JH, et al: Nitrite reduction to nitric oxide by deoxyhe-moglobin vasodilates the human circulation. Nat Med 2003; 9:1498-1505
23. Crawford J, Chacko BK, Pruitt HM, et al: Transduction of no bioactivity by the red blood cell in sepsis: Novel mechanisms of vasodilation during acute inflammatory disease. Blood 2004; 104:1375-1382
24. Feelisch M, Rassaf T, Mnaimneh S, et al: Concomitant S-, N-, and heme-nitros(yl)a-tion in biological tissues and fluids: Implications for the fate of no in vivo. FASEB J 2002; 16:1775-1785
25. 3 by the concerted nitrite reductase and anhydrase activity of hemoglobin. Nat Chem Biol 2007; 3:785-794
26. Crawford J, Isbell ST, Huang Z, et al: Hyp-oxia, red blood cells, and nitrite regulate no-dependent hypoxic vasodilation. Blood 2006; 107:566-574
27. 2 no-linked allosteric function. J Biol Chem 2002; 277:27818-27828
28. Gladwin M, Raat NJH, Shiva S, et al: Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cyto-protection, and vasodilation. Am J Physiol Heart Circ Physiol 2006; 291:H2026-H2035
29. Baskurt O, Gelmont D, Meiselman HJ: Red blood cell deformability in sepsis. Am J Re-spir Crit Care Med 1998; 157:421-427
30. Bellary S, Anderson KW, Arden WA, et al: Effect of lipopolysaccharide on the physical conformation of the erythrocyte cytoskeletal proteins. Life Sciences 1995; 56:91-98
31. Siegel J, Greenspan M, Del Guercio LRM: Abnormal vascular tone, defective oxygen transport and myocardial failure in human septic shock. Ann Surg 1967; 165:504-517
32. Alzawahra W, Talukder MAH, Liu X, et al: Heme proteins mediate the conversion of nitrite to nitric oxide in the vascular wall. Am J Physiol (Heart Circ Physiol) 2008; 295: H499-H508
33. Feelisch M, Fernandez BO, Bryan NS, et al: Tissue processing of nitrite in hypoxia: An intricate interplay of nitric oxide-generating and-scavenging systems. J Biol Chem 2008; 283:33927-33934
34. Shiva S, Wang X, Ringwood LA, et al: Ceru-loplasmin is a no oxidase and nitrite synthase that determines endocrine no homeostasis. Nat Chem Biol 2006; 2:486-493
35. Chiarla C, Giovannini I, Siegel JH: Patterns of correlation of plasma ceruloplasmin in sepsis. J Surg Res 2008; 144:107-110
36. Dejam A, Hunter CJ, Tremonti C, et al: Nitrite infusions in humans and nonhuman primates: Endocrine effects, pharmacokinet-ics, and tolerance formation. Circulation 2007; 116:1821-1831
37. Lundberg J, Weitzberg E, Gladwin MT: The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev 2008; 7:156-167
38. Wang X, Bryan NS, MacArthur PH, et al: Measurement of no levels in the red cell: Validation of tri-iodide based chemilumines-cence with acid-sulfanilamide pre-treatment. J Biol Chem 2006; 281:26994-27002
39. Basu S, Wang X, Gladwin MT, et al: Chemi-luminescent detection of s-nitrosated proteins: Comparison of tri-iodide, copper/co/ cysteine and modified copper/cysteine methods. Methods Enzymol 2008; 440: 138-156
40. Rassaf T, Feelisch M, Kelm M: Circulating no pool: Assessment of nitrite and nitrosopro-teins in blood and tissue. Free Radic Biol Med 2004; 36:413-422
41. Jourd'heuil D, Gray L, Grisham MB: S-nitrosothiol formation in blood of lipopo-lysaccharide-treated rats. Biochem Biophys Res Commun 2000; 273:22-26
42. Jensen F: Nitrite transport into pig erythro-cytes and its potential biological role. Acta Physiol Scand 2005; 184:243-251
43. May J, Qu ZC, Xia L, et al: Nitrite uptake and metabolism and oxidant stress in human erythrocytes. Am J Physiol (Cell Physiol) 2000; 279:C1946-C1954
44. Bernard G, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein c for severe sepsis. N Engl J Med 2001; 344:699-709